Scarica l'app Stockscreener
12.62
3.59%
-0.47
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$13.09
Aprire:
$13
Volume 24 ore:
587.32K
Relative Volume:
0.76
Capitalizzazione di mercato:
$518.89M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-15.39
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
-0.08%
1M Prestazione:
+26.07%
6M Prestazione:
-11.56%
1 anno Prestazione:
-64.84%
Intervallo 1D:
$12.60
$13.00
Intervallo di 1 settimana:
$11.84
$13.22
Portata 52W:
$6.32
$39.37
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
12.62 | 538.22M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
RxSight, Inc.'s (NASDAQ:RXST) 28% Price Boost Is Out Of Tune With Revenues - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Divisadero Street Capital Management LP Has $2.85 Million Stock Position in RxSight, Inc. $RXST - MarketBeat
How Does Aditya Birla Capital Limited Compare to SP500 Over the Last 3 YearsChart Pattern Recognition & Free High Yield Portfolio Picks - earlytimes.in
What Makes Mason Infratech Limited a Strong Contender in YEARInstitutional Holding Changes & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) Given Average Rating of "Reduce" by Brokerages - MarketBeat
RxSight, Inc. $RXST Shares Purchased by Brown Capital Management LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
Why RxSight Inc. stock could benefit from AI revolution2025 Market Overview & Weekly Market Pulse Updates - Newser
RxSight price target raised to $10 from $9 at Morgan Stanley - MSN
How RxSight Inc. stock benefits from global expansion2025 Market Overview & Safe Entry Point Identification - Newser
Morgan Stanley Maintains RxSight (RXST) Equal-Weight Recommendation - Nasdaq
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight (RXST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
RxSight (RXST) Sees Analyst Rating Update from Morgan Stanley | - GuruFocus
RXST ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - The National Law Review
RXST LAWSUIT ALERT: Levi & Korsinsky Notifies RxSight, Inc. InvestorsLead Plaintiff Deadline September 22, 2025 - The National Law Review
Grandeur Peak Global Advisors LLC Acquires 94,871 Shares of RxSight, Inc. $RXST - MarketBeat
Investors in RxSight, Inc. (RXST): Protect Your RightsContact Levi & Korsinsky Before September 22, 2025 - The National Law Review
RA CAPITAL MANAGEMENT, L.P.'s RxSight Inc(RXST) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
What Analysts Say Is Shifting the Story for RxSight Shares - Yahoo Finance
Ensign Peak Advisors Inc Decreases Stock Position in RxSight, Inc. $RXST - MarketBeat
Atika Capital Management LLC Sells 158,366 Shares of RxSight, Inc. $RXST - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 77% loss over the past year - simplywall.st
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
SG Americas Securities LLC Purchases 30,333 Shares of RxSight, Inc. $RXST - MarketBeat
AXQ Capital LP Invests $405,000 in RxSight, Inc. $RXST - MarketBeat
What analysts say about RxSight Inc stockVolume Analysis Techniques & Hedge Fund-Style Analysis Now Free - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
76,728 Shares in RxSight, Inc. $RXST Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Artisan Partners Limited Partnership Grows Position in RxSight, Inc. $RXST - MarketBeat
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
Will RxSight Inc. stock attract ESG investors2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - The Manila Times
What risks investors should watch in RxSight Inc. stockTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Is RxSight Inc. stock a defensive play in 2025Portfolio Update Report & Long-Term Safe Investment Plans - newser.com
Combining price and volume data for RxSight Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
Can RxSight Inc. stock continue upward trend2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):